ATTENTION: Investment scam - distribution of fake prospectus and impersonation of HMC Capital staffmore details
Investment Scams Alert
HMC Capital has been made aware of scams where unauthorised persons falsely impersonating representatives of HMC Capital are approaching members of the public via calls, emails or social media channels to market fraudulent investment scheme, to obtain personal information, or to provide unauthorised payment confirmation.
If you are ever contacted by a representative of HMC Capital via email it will always come from an address in the form of “@hmccapital.com.au” only. If you are unable to verify such persons’ identities and confirm their connection with HMC Capital, please do not provide these individuals with your personal/corporate data or respond to any fund transfer request. Please do not open hyperlinks, attachments and QR codes from any unfamiliar sources. Be suspicious of anyone offering you easy money. Investment scams often involve promises of big payouts for little or no risk, quick money, or guaranteed returns.
What to do if you suspect you are a victim of an Investment Scam?
HMC Capital (ASX: HMC) Group Managing Director & CEO, David Di Pilla, reflects on a record year of growth for the Group.
We look back on 2023 to celebrate the Group’s achievements, including successfully closing over $2bn in our unlisted Institutional funds and the acquisition of the $1.2bn Healthscope hospital portfolio. Our private equity vehicle, HMC Capital Partners, ended the year with strong momentum with our portfolio company Sigma Healthcare announcing a transformational merger proposal with Chemist Warehouse, one of Australia’s largest and most successful retailers.
The HMC Capital team extends warm wishes for a safe and joyful festive season to all.